2026 Feb;25(1)
This article was developed and reviewed by experienced healthcare professionals specializing in obesity medicine, peptide therapy, hormone optimization, wellness, and bariatric surgery
Clinical data has shown meaningful improvements in blood sugar regulation, a reduced risk of progression from prediabetes to type 2 diabetes, and, for many patients, favourable shifts in blood pressure and cholesterol as excess weight decreases
The capsules are a bit large
Conclusion In conclusion, the emerging observation that some complications of diabetes are associated with an hyperactivation of RAAS has provided the pathophysiological basis to study the effects of GLP1-RA and SGLT2-i on RAAS to better explain the cardio-reno-protective effect demonstrated by the clinical trials, beyond their role on glucose control
The median time to prescription was 1 day or less, and compounded GLP-1 receptor agonistscontaining nonFDA-approved inactive ingredientswere commonly mailed without patient confirmation